Functional alterations of the microflora in patients with ulcerative colitis

Area of Science:

• Gastroenterology
• Microbiology
• Biochemistry

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
• Gut microflora plays a crucial role in inflammatory bowel diseases.
• Sulphasalazine is a common treatment for UC.

Purpose of the Study:

• To investigate microflora-associated metabolic characteristics in patients with inactive ulcerative colitis on sulphasalazine.
• To correlate these characteristics with the extent of UC.
• To compare metabolic profiles between UC patients and healthy controls.

Main Methods:

• Faecal samples were collected from patients with varying degrees of UC (proctitis, left-sided, total colitis) and age-/sex-matched controls.
• Measurements included cholesterol to coprostanol conversion, urobilinogen production, and fecal tryptic activity (FTA).
• Beta-aspartylglycine levels were also assessed.

Main Results:

• No significant differences in metabolic parameters were found across different UC disease extents.
• Patients with colitis exhibited a lower coprostanol ratio and urobilinogen level compared to controls.
• Fecal tryptic activity (FTA) was significantly higher in UC patients than in controls (p < 0.05).
• Beta-aspartylglycine was undetectable in all samples.

Conclusions:

• Patients with ulcerative colitis treated with sulphasalazine demonstrate abnormal gut microflora metabolic activity.
• These alterations are present regardless of disease extent.
• The findings suggest a link between sulphasalazine treatment, gut microbiota, and metabolic changes in UC.